Clinical Research Directory
Browse clinical research sites, groups, and studies.
Blood Biomarkers for Alzheimer Disease and Neuro-injury to Estimate the Association With Cognitive/Functional Decline and Mortality in a Real-world Population of GERiatric Hospitalized Patients (BAD-GER)
Sponsor: Istituto Nazionale di Ricovero e Cura per Anziani
Summary
The BAD-GER study is a multicenter, prospective, three-arm observational study serving to validate a prognostic biomarker algorithm for mortality and hospital readmission; this algorithm will be developed through the retrospective analysis of Alzheimer's Disease and neurodegeneration biomarkers in an already available discovery cohort of 700 previously hospitalized geriatric patients.
Official title: Blood Biomarkers for Alzheimer Disease and Neuro-injury to Estimate the Association With Cognitive/Functional Decline and Mortality in a Real-world Population of GERiatric Hospitalized Patients (BAD-GER): a Multicenter, Observational, 3-arms, Prospective Study
Key Details
Gender
All
Age Range
65 Years - Any
Study Type
OBSERVATIONAL
Enrollment
400
Start Date
2025-04-09
Completion Date
2026-06-30
Last Updated
2026-02-27
Healthy Volunteers
No
Conditions
Interventions
collection of blood samples
Serum and EDTA-plasma samples will be collected at baseline
Locations (3)
IRCCS INRCA Hospital
Ancona, Italy
IRCCS INRCA Hospital
Fermo, Italy
Policlinico Universitario
Messina, Italy